Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

被引:11
|
作者
Hung, Tsung-Min [1 ,2 ]
Chen, Chien-Cheng [2 ,3 ]
Lin, Chien-Yu [1 ,2 ]
Ng, Shu-Hang [2 ,3 ]
Kang, Chung-Jan [2 ,4 ]
Huang, Shiang-Fu [2 ,4 ]
Liao, Chun-Ta [2 ,4 ]
Fan, Kang-Hsing [1 ,2 ]
Wang, Hung-Ming [2 ,5 ]
Chang, Joseph Tung-Chieh [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan
关键词
Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Prognosis; Prepontine cistern invasion; Distant metastasis; Intracranial extension; Head and neck cancer; BARR-VIRUS DNA; PHASE-II TRIAL; F-18-FDG PET; EXPERIENCE; CHEMOTHERAPY; CANCER;
D O I
10.1016/j.oraloncology.2013.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the prognostic value of prepontine cistern invasion (PPCI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Materials and methods: Five hundred and four non-disseminated NPC patients who underwent magnetic resonance imaging examination before radical IMRT between November 2000 and December 2008 were retrospectively reviewed. The diagnostic criteria for PPCI were tumor invasion through the posterior cortex of clivus and extension into the prepontine cistern. Results: The median follow-up of the patients in this study was 63.5 months. PPCI was found in 44 patients (25% of T4 patients). The 5-year progression-free survival (PFS), local control (LC), distant metastasis- free survival (DMFS), and overall survival (OS) of all patients, with and without PPCI, were 44.3% and 70.5% (p < 0.001), 84.4% and 89.1% (p = 0.376), 66.6% and 87.3% (p < 0.001), and 59.6% and 80.2% (p < 0.001), respectively. In T4 patients with PPCI and without PPCI, the 5-year PFS, LC, DMFS, and OS were 44.3% and 62.5% (p = 0.023), 84.4% and 84.9% (p = 0.946), 66.6% and 83.1% (p = 0.022), and 59.6% and 71.0% (p = 0.045), respectively. Using multivariate analysis, PPCI was found to be an independent poor prognostic factor for PFS (HR = 1.816; p = 0.007), DMFS (HR = 1.928; p = 0.045), and OS (HR = 1.798; p = 0.016). Conclusion: Prepontine cistern invasion was an independent prognostic factor for poor DMFS and OS but not LC in NPC patients treated with IMRT, even within T4 patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [31] Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
    Tao, Chang-Juan
    Liu, Xu
    Tang, Ling-Long
    Mao, Yan-Ping
    Chen, Lei
    Li, Wen-Fei
    Yu, Xiao-Li
    Liu, Li-Zhi
    Zhang, Rong
    Lin, Ai-Hua
    Ma, Jun
    Sun, Ying
    CHINESE JOURNAL OF CANCER, 2013, 32 (09) : 494 - 501
  • [32] Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Lei
    Sun, Ying
    Qi, Zhen-Yu
    Zhou, Guan-Qun
    Liu, Li-Zhi
    Li, Li
    Lin, Ai-Hua
    Ma, Jun
    CHINESE JOURNAL OF CANCER, 2016, 35 : 103
  • [33] Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
    Tian, Yun-Ming
    Liu, Ming-Zhu
    Zeng, Lei
    Bai, Li
    Lin, Cheng-guang
    Huang, Shao-Min
    Deng, Xiao-Wu
    Chong-Zhao
    Lu, Tai-Xiang
    Han, Fei
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05): : 1246 - 1252
  • [34] Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
    Songthong, Anussara
    Chakkabat, Chakkapong
    Kannarunimit, Danita
    Lertbutsayanukul, Chawalit
    RADIOLOGY AND ONCOLOGY, 2015, 49 (02) : 155 - 162
  • [35] Olfactory change after intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Wang, Jing-Jie
    Liang, Kai-Li
    Twu, Chih-Wen
    Lin, Jin-Ching
    Jiang, Rong-San
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 (11) : 1059 - 1062
  • [36] Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
    Pan, Xin-Bin
    Liu, Yang
    Li, Ling
    Qu, Song
    Chen, Long
    Liang, Shi-Xiong
    Chen, Kai-Hua
    Liang, Zhong-Guo
    Zhu, Xiao-Dong
    AGING-US, 2020, 12 (02): : 1838 - 1847
  • [37] LONG-TERM OUTCOMES OF EARLY-STAGE NASOPHARYNGEAL CARCINOMA PATIENTS TREATED WITH INTENSITY-MODULATED RADIOTHERAPY ALONE
    Su, Sheng-Fa
    Han, Fei
    Zhao, Chong
    Chen, Chun-Yan
    Xiao, Wei-Wei
    Li, Jia-Xin
    Lu, Tai-Xiang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 327 - 333
  • [38] Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
    Yin, Wen-Jing
    Chen, Dong-Ping
    Wang, Meng-Yao
    Zheng, Lu
    Dong, En-Lai
    Liu, Jin-Quan
    Qi, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (16)
  • [39] MRI-detected skull-base invasion Prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma
    Cheng, Yi-Kan
    Liu, Li-Zhi
    Jiang, Ning
    Yue, Dan
    Tang, Ling-Long
    Zhang, Fan
    Lin, Li
    Liu, Xu
    Chen, Lei
    Ma, Jun
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (10) : 905 - 911
  • [40] Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    YuXiang He
    Ying Wang
    PengFei Cao
    Lin Shen
    YaJie Zhao
    ZiJian Zhang
    DengMing Chen
    TuBao Yang
    XinQiong Huang
    Zhou Qin
    YouYi Dai
    LiangFang Shen
    ChineseJournalofCancer, 2016, 35 (12) : 725 - 734